House Majority Leader Steve Scalise Undergoing Stem Cell Transplant for Cancer Treatment

Scalise's Absence Reduces GOP House Majority, Adding to Legislative Challenges Amid Funding Deadlines

House Majority Leader Steve Scalise is undergoing a stem cell transplant as part of his treatment for multiple myeloma, a type of blood cancer.
Scalise's absence from Washington until February reduces the Republican majority in the House from three to two, making it more difficult to pass legislation.
Scalise's office announced that he had a positive response to induction chemotherapy completed last month, making him eligible for the stem cell transplant.
Despite his absence, Scalise will continue to work remotely until he returns to Washington next month.
The House faces significant legislative challenges in Scalise's absence, including funding government agencies by January 19 to avoid a partial government shutdown.